Similarly, patients with SSc with a higher percentage of CEACAM-positive monocytes showed higher levels of serum KL-6 and lower FVC, indicating that patients with increased CEACAM-positive monocytes presented with active and progressive ILD. The gene discussed is MUC1; the disease is systemic sclerosis.